ライフサイエンスコーパス: radioimmunoassay

1 fragment of type I collagen (ICTP) (using a radioimmunoassay).

2 lysis in combination with a highly sensitive radioimmunoassay.

3 P1-98 concentrations were determined using a radioimmunoassay.

4 until ferritin determination by traditional radioimmunoassay.

5 eely moving cats and a sensitive solid phase radioimmunoassay.

6 terone levels were determined by solid-phase radioimmunoassay.

7 lso determined in response to E and E-BSA by radioimmunoassay.

8 , proinsulin, and C-peptide were measured by radioimmunoassay.

9 s of prostaglandin E2 (PGE2) was examined by radioimmunoassay.

10 g hormone) and testosterone were measured by radioimmunoassay.

11 subsequent changes in cAMP were measured by radioimmunoassay.

12 chromatographic method and then analyzed by radioimmunoassay.

13 icrodialysates was analyzed by a solid-phase radioimmunoassay.

14 chromatographic method, and then analyzed by radioimmunoassay.

15 enosine monophosphate (cAMP) was measured by radioimmunoassay.

16 ike immunoreactivity (SP-LI) was measured by radioimmunoassay.

17 nd ISO treatments were also measured using a radioimmunoassay.

18 in the bovine aqueous humor was assessed by radioimmunoassay.

19 e product 6-keto-PGF1alpha, were measured by radioimmunoassay.

20 centration of PRL in serum was determined by radioimmunoassay.

21 pase substrates, and measured PRL release by radioimmunoassay.

22 for 17beta-estradiol metabolite formation by radioimmunoassay.

23 tin levels in the plasma were measured using radioimmunoassay.

24 3',5'-monophosphate (cGMP) were assessed by radioimmunoassay.

25 ocusing gel electrophoresis and specific TRH radioimmunoassay.

26 ECP release was measured by radioimmunoassay.

27 a samples were assayed for hormone levels by radioimmunoassay.

28 centrations of dynorphin B were measured via radioimmunoassay.

29 eukin-1alpha (rHuIL-1alpha), was assessed by radioimmunoassay.

30 Serum gastrin levels were determined by radioimmunoassay.

31 with IL-1beta plus hormones was estimated by radioimmunoassay.

32 m osteocalcin levels, which were measured by radioimmunoassay.

33 evels from baseline samples were analyzed by radioimmunoassay.

34 n on D cells was measured by [Ca(2+)](i) and radioimmunoassay.

35 els were measured using a nonchromatographic radioimmunoassay.

36 nd met-enkelphalin levels were determined by radioimmunoassay.

37 lasma concentrations of ddI were measured by radioimmunoassay.

38 re measured at 0, 1, 3, 6, 12, and 24 hrs by radioimmunoassay.

39 OFQ/N peptide in the SCN was demonstrated by radioimmunoassay.

40 pernate assayed for ferritin by a commercial radioimmunoassay.

41 last injection to measure met-enkephalin by radioimmunoassay.

42 ing hormone (LH) in serum were determined by radioimmunoassay.

43 E2 levels were assessed by radioimmunoassay.

44 2 (TXB2), the stable metabolite of TXA2, via radioimmunoassay.

45 CGRP release was measured by radioimmunoassay.

46 lecystokinin concentrations were measured by radioimmunoassay.

47 ars in 1984-1987 were analyzed in 1993 using radioimmunoassay.

48 E2 release into the media was quantitated by radioimmunoassay.

49 IgG antibody concentrations were assessed by radioimmunoassay.

50 expressed the wild-type IR, as determined by radioimmunoassay.

51 Histamine was measured by radioimmunoassay.

52 hed from serum cotinine levels determined by radioimmunoassay.

53 2) isometric tension recording, and (3) cGMP radioimmunoassay.

54 A concentrations were measured by monoclonal radioimmunoassay.

55 and cells with 0.1 N HCl and was analyzed by radioimmunoassay.

56 the cellular content of CCK 8 as measured by radioimmunoassay.

57 ase polymerase chain reaction and protein by radioimmunoassay.

58 suring porcine insulin concentration using a radioimmunoassay.

59 ess calbindin 6- to 35-fold as determined by radioimmunoassay.

60 growth hormone, and insulin were measured by radioimmunoassay.

61 BPAEC supernatants and in plasma measured by radioimmunoassay.

62 hosphate (cAMP) accumulation was measured by radioimmunoassay.

63 es were used to extract and quantitate FN by radioimmunoassay.

64 bulin levels were concurrently determined by radioimmunoassay.

65 and corticosterone were measured by using a radioimmunoassay.

66 detected in the anterior pituitary gland by radioimmunoassay.

67 Glomerular cAMP was measured by radioimmunoassay.

68 cted and evaluated for F(M/V)DIPEN levels by radioimmunoassay.

69 E was detected in HLEC-conditioned medium by radioimmunoassay.

70 Gastrin and histamine were measured by radioimmunoassay.

71 inding proteins 1, 2, and 3 were measured by radioimmunoassay.

72 2 levels were determined by highly sensitive radioimmunoassay.

73 d with behavioral measures were evaluated by radioimmunoassay.

74 nocytochemistry and proinsulin secretion, by radioimmunoassay.

75 testosterone and estradiol were measured by radioimmunoassay.

76 d samples were taken for PRL measurements by radioimmunoassay.

77 ain areas of TO strain mice were measured by radioimmunoassay.

78 RH and corticotropin (ACTH) were measured by radioimmunoassay.

79 Serum 25(OH)D was measured by radioimmunoassay.

80 5(OH)D concentrations were assessed by using radioimmunoassay.

81 to smaller peptide products was measured by radioimmunoassay.

82 h group of donors was evaluated by desmosine radioimmunoassay.

83 ent of fasting blood biochemistry indexes by radioimmunoassay.

84 al DA, SP, and ME were determined by HPLC or radioimmunoassay.

85 NT-ir measured with immunohistochemistry and radioimmunoassay.

86 e southeastern United States with the use of radioimmunoassay.

87 oth studies, 25(OH)D levels were measured by radioimmunoassay.

88 ces on the release of OT and VP, measured by radioimmunoassay.

89 plasma and red-blood-cell concentrations by radioimmunoassay.

90 l tubules were assayed for Ang II content by radioimmunoassay.

91 were measured in plasma and brain regions by radioimmunoassay.

92 t was not detectable in the control group by radioimmunoassay.

93 of PACAP peptides in the IMG as measured by radioimmunoassay.

94 nositol triphosphate levels were measured by radioimmunoassay.

95 alpha,5 alpha-THP) levels were determined by radioimmunoassay.

96 d serial blood samples were collected for LH radioimmunoassay.

97 17 was demonstrated in SEB-1 sebocytes using radioimmunoassay.

98 -patch clamp recordings and hormone-specific radioimmunoassays.

99 prostaglandin E2 production was assessed by radioimmunoassays.

100 . denitrificans NDH-1 has been determined by radioimmunoassays.

101 in D (1,25(OH)(2)D) were assayed by specific radioimmunoassays.

102 a matrices, and benchmarked versus ELISA and radioimmunoassays.

103 IA2As), and ZnT8 (ZnT8As) were measured with radioimmunoassays.

104 -related biomarkers were determined by using radioimmunoassays.

105 d E1S were determined using highly sensitive radioimmunoassays.

106 F, and VEGF in tumor tissue were measured by radioimmunoassays.

107 dium, accumulation of PGE(2) was measured by radioimmunoassay, [(3)H]myo-inositol phosphate productio

108 PR in sea urchin egg homogenates including a radioimmunoassay, a Ca2+ release assay, and a thin layer

109 c specificity was confirmed by a competition radioimmunoassay against ARH-77 human myeloma cells.

110 in reaction, immunoblot, microtitration, and radioimmunoassay analyses.

111 The use of these MAbs in a colony blot radioimmunoassay analysis revealed that expression of bo

112 category were 0.80 (95% CI: 0.61, 0.99) for radioimmunoassay and 1.03 (95% CI: 0.83, 1.22) for micro

113 rum AFP levels were analyzed by using both a radioimmunoassay and an immunoenzymatic method.

114 eriments were analysed using chromatography, radioimmunoassay and bioassay, and no significant degrad

115 47) EPO levels at admission were measured by radioimmunoassay and compared with mortality and neurolo

116 evels of ICTP and IL-1 were determined using radioimmunoassay and enzyme-linked immunosorbent assay t

117 cellular IP(3) and Ca(2+) accumulation using radioimmunoassay and Fluo-3 fluorometry, respectively.

118 a-6E,8C,11Z,14Z-tetraenoic acid (5-HETE), by radioimmunoassay and high-performance liquid chromatogra

119 t that Leu-enkephalin has been identified by radioimmunoassay and HPLC analysis in the CNS of the Aus

120 n stimulated by beta-agonist was assessed by radioimmunoassay and membrane-delineated flow through cy

121 Plasma gastrin was measured by radioimmunoassay and mRNAs encoding gastrin, somatostati

122 and eosinophil-derived neurotoxin [EDN]) by radioimmunoassay and quantitated eosinophil degranulatio

123 of the amygdala, as measured by solid phase radioimmunoassay and quantitative real-time PCR.

124 Here we have used a newly developed radioimmunoassay and RP-HPLC to detect mppOFQ/N(160-187)

125 The test was first established in 1983 as a radioimmunoassay and soon thereafter converted into ELIS

126 LISA with saliva was more sensitive than the radioimmunoassay and that the results correlated better

127 Radioimmunoassay and Western blot analysis showed that c

128 ery) were subsequently sacrificed for ELISA, radioimmunoassay and western blot measurement of orexins

129 Plasma IGF-I and IGFBPs were measured by radioimmunoassay and Western ligand blot, respectively,

130 rent regions of proSAAS were used to develop radioimmunoassays and examine the processing profile of

131 Solid-phase radioimmunoassays and intact cell-binding assays confirm

132 may have many other applications, including radioimmunoassays and radioimmunotherapy.

133 oss-link fragment of type I collagen [ICTP]; radioimmunoassay), and interleukin-1beta (enzyme-linked

134 8 were determined by Northern blot analysis, radioimmunoassay, and an enzyme-amplified sensitivity im

135 insulin secretion quantified using ELISA or radioimmunoassay, and glucose uptake determined through

136 IGFBP-1, and IGFBP-2 levels were measured by radioimmunoassay, and IGFBP-3 by immunoradiometric assay

137 in the neocortex, as shown by real-time PCR, radioimmunoassay, and immunohistochemistry.

138 Leptin was measured in serum and vitreous by radioimmunoassay, and leptin and leptin receptor were lo

139 sing high-performance liquid chromatography, radioimmunoassay, and mass spectrometry, we identified t

140 NPY in cerebrospinal fluid were measured by radioimmunoassay, and messenger RNA levels were assessed

141 iol levels (E2) were measured yearly by 125I radioimmunoassay, and osteopenia/osteoporosis was determ

142 Levels of cAMP were determined by radioimmunoassay, and protein levels by Western blot and

143 asurement, whole-cell patch clamp recording, radioimmunoassay, and reverse-transcription polymerase c

144 of the urine, extraction with ethyl acetate, radioimmunoassay, and separation of free from bound ster

145 Myocardial cGMP was measured by radioimmunoassay, and serum nitrogen oxide levels (NOx =

146 e release was measured biochemically using a radioimmunoassay, and the targeting of peptidergic vesic

147 measured serum insulin levels by a validated radioimmunoassay, and we measured glucose levels.

148 tein (RBP) concentrations were determined by radioimmunoassays, and transthyretin, alpha(1)-acid glyc

149 lysis; fasting serum leptin concentration by radioimmunoassay; and lipid profile, fasting insulin, gl

150 MP) levels in the brainstem were analysed by radioimmunoassay as an index of nitric oxide generation.

151 ma levels of ME, BE, and SP were measured by radioimmunoassay at preincision, preemergence, and for 3

152 The stronger association for the radioimmunoassay-based studies could reflect differences

153 s studied using region-specific antisera and radioimmunoassays, biosynthetic labeling, immunoprecipit

154 In solid-phase radioimmunoassay, both sc(Fv)(2) and [sc(Fv)(2)](2) exhi

155 stnatal brain (as previously demonstrated by radioimmunoassay) but also in the embryonic central nerv

156 ntal and resistant cell lines as measured by radioimmunoassay, but flow cytometric data showed that n

157 ameters of SSC, including insulin secretion (radioimmunoassay), cell membrane potential, various ion

158 Radioimmunoassay, cell-based assays, and mouse brain imm

159 oxyvitamin D concentrations were measured by radioimmunoassay, chemiluminescent assay, ELISA, or mass

160 evels within 250-400 ng/ml (measured using a radioimmunoassay, Coat-A-Count Serum Morphine) and was s

161 re evaluated for HPV-11 titer by competitive radioimmunoassay (cRIA) and for neutralization by use of

162 dict LC-MS/MS-equivalent concentrations from radioimmunoassay data (1988-2006 surveys; n = 38,700) an

163 Plasma aldosterone levels by radioimmunoassay demonstrated a 4- to 5-fold increase in

164 Radioimmunoassay demonstrated catestatin release from th

165 BNP mRNA was detected in CFs, and a specific radioimmunoassay demonstrated that BNP(1-32) was secrete

166 Neuropeptide radioimmunoassays demonstrated the following statistical

167 the serum IgG result than the results of the radioimmunoassay did, with an overall sensitivity of 82%

168 ensin II, and aldosterone were determined by radioimmunoassay every 15 min before, during and after t

169 a variety of detection modalities, including radioimmunoassays, fluorescence-based detection assays,

170 Radioimmunoassay for albumin was used for all specimens

171 ressed the transgene, as determined by serum radioimmunoassay for human growth hormone.

172 logical techniques in addition to subsequent radioimmunoassay for LH, we have found that anesthesia b

173 A radioimmunoassay for urinary tetrahydrocortisol (THF) is

174 Radioimmunoassays from LoVo-derived secreted products in

175 Currently, there is radioimmunoassay, gas chromatography-mass spectrometry (

176 A radioimmunoassay has been developed for the measurement

177 d-O staining, cyclic adenosine monophosphate radioimmunoassay, immunofluorescence microscopy, and glu

178 These observations, however, predated radioimmunoassay, immunohistochemical staining, and othe

179 ic GAL activity was measured in others using radioimmunoassay, immunohistochemistry and in situ hybri

180 (BNP) natriuretic peptides were measured by radioimmunoassay in 122 consecutive patients referred to

181 Serum leptin concentrations were measured by radioimmunoassay in 197 adolescents aged 13-16 y who wer

182 (EBCT), and measured serum 1,25(OH)2D3 with radioimmunoassay in 283 high-risk subjects (51 [180%] bl

183 , serum IGF-1 and T4 levels were measured by radioimmunoassay in an additional 200 rats exposed to tr

184 emistry, and secreted ET-1 was quantified by radioimmunoassay in both cell types.

185 Hormone levels were measured by radioimmunoassay in control and Sst(-/-) mice in vivo an

186 Plasma aldosterone was measured by radioimmunoassay in core laboratories at baseline and du

187 Levels of ET-1 and ET-3 were determined by radioimmunoassay in ocular tissues of normal rats, and i

188 hrelin, insulin, and leptin were measured by radioimmunoassay in plasma samples drawn 38 times throug

189 We measured secretoneurin levels by radioimmunoassay in samples obtained early after ICU adm

190 zinc transporter 8 (ZnT8A) were measured by radioimmunoassay in sera collected from children and you

191 lin immunoreactive levels were determined by radioimmunoassay in the preoptic area, a major terminal

192 solated as the trans isomer by HPLC and by a radioimmunoassay in which monoclonal antibodies specific

193 ll as fasting plasma ghrelin concentrations (radioimmunoassay) in 15 Caucasians (8 men and 7 women, 3

194 mediates (total) were measured by a two-step radioimmunoassay; independent determinations of intact p

195 ization of the perifornical area and peptide radioimmunoassays indicated global loss of hypocretins,

196 Thin layer chromatography and radioimmunoassays indicated that the secosteroid product

197 Using sensitive radioimmunoassays, interleukin-4 (IL-4), IL-10, IL-12 p4

198 te (cAMP) in tissue extracts was measured by radioimmunoassay, IP3 production was measured by ion-exc

199 linded operator using a standard competitive radioimmunoassay kit (Peninsula Laboratories, Bachem Ltd

200 Serum 25(OH)D was measured with a radioimmunoassay kit in 20 289 participants in NHANES 20

201 leotides was determined using a 125I-labeled radioimmunoassay kit.

202 lar ratio (IGF-I/IGFBP-3) were measured with radioimmunoassay kits in stored blood samples from the p

203 As determined with radioimmunoassay, labeling effectiveness with scFv:MBD w

204 the serum thyroid-stimulating hormone (TSH) radioimmunoassay led to the discovery that many patients

205 in the dialysates, but other methods such as radioimmunoassay may be employed.

206 Finally, using a radioimmunoassay, MCH/MCH-like peptide was detected in r

207 Radioimmunoassays measured serum parathyroid hormone and

208 Using a combination of radioimmunoassay measurement of ELH secretion, electroph

209 n(1-13) was measured in indicated tissues by radioimmunoassay method.

210 Radioimmunoassay of acetylated acid extracts was used to

211 Plasma renin activity was assessed by radioimmunoassay of angiotensin I.

212 Melatonin was assessed by radioimmunoassay of its metabolite, 6-hydroxymelatonin s

213 elease of PGI(2) from rat aorta, assessed by radioimmunoassay of its stable metabolite, 6-keto PGF(1a

214 Radioimmunoassay of plasma progesterone before and after

215 n in chromogranin A, as judged by catestatin radioimmunoassay of size-fractionated chromaffin granule

216 degradation of skin collagen was measured by radioimmunoassay of soluble cross-linked telopeptides.

217 Norway, 25-OH D levels were measured using a radioimmunoassay on samples from late pregnancy in 109 w

218 oresis (SDS-PAGE) and direct quantitation by radioimmunoassay or cytofluorometry defines four distinc

219 Growth factor production was measured by radioimmunoassay or enzyme-linked immunosorbent assay.

220 ood sampling to determine plasma oxytocin by radioimmunoassay or for in vivo extracellular recording

221 For assessment of internalized receptors by radioimmunoassay or immunofluorescence, a triple c-myc e

222 Measurements of hypothalamic peptides via radioimmunoassay or real-time quantitative PCR revealed

223 (125)I-IGF-2 Western ligand blotting (WLB), radioimmunoassay, or 2-site immunoradiometric assay (IRM

224 lism of radioimmunoconjugates using cellular-radioimmunoassays, Percoll gradient fractionation of cel

225 The radioimmunoassay procedure involves enzymic hydrolysis o

226 of AM biology, the influence of factor H on radioimmunoassay quantification of AM, and the possible

227 liquid chromatography (HPLC) and solid-phase radioimmunoassay, respectively, for 3 days.

228 e measured using electrical bioimpedance and radioimmunoassay, respectively.

229 d using a chemiluminescent immunoassay and a radioimmunoassay, respectively.

230 firefly luciferin-luciferase (L/L) assay and radioimmunoassay, respectively.

231 nzyme-linked immunosorbent assay (ELISA) and radioimmunoassay, respectively.

232 Measurements of cAMP levels with radioimmunoassays revealed that phorbol esters did not a

233 The Truquant BR radioimmunoassay (RIA) (Biomira Diagnostics Inc, Rexdale

234 of endogenous serum leptin as determined by radioimmunoassay (RIA) after sucrose gradient centrifuga

235 IgM antifibrillin 1 autoantibodies, using a radioimmunoassay (RIA) and a human recombinant fibrillin

236 evels of ICTP and IL-1 were determined using radioimmunoassay (RIA) and enzyme-linked immunosorbent a

237 ve assay to measure endogenous OT, including radioimmunoassay (RIA) and enzyme-linked immunosorbent a

238 Prostaglandin E2 (PGE2) was assayed using a radioimmunoassay (RIA) and mass spectroscopy.

239 erum oestradiol analyses were performed with radioimmunoassay (RIA) and SOD activity was measured in

240 sheep, histamine in BALF was measured with a radioimmunoassay (RIA) before and after the segmental an

241 Radioimmunoassay (RIA) demonstrates that about 500 000 C

242 Radioligand binding assay (RLA) and radioimmunoassay (RIA) development involves consideratio

243 Radioimmunoassay (RIA) employing iodinated ligands repre

244 Insulin was detected by radioimmunoassay (RIA) in the medium of GLP-1-treated ce

245 Radioimmunoassay (RIA) of IL-12 p40 protein on supernata

246 d via acid maceration and hormone changes by radioimmunoassay (RIA) or enzyme-linked immunosorbent as

247 h-pressure liquid chromatography and the EEP radioimmunoassay (RIA) revealed that pGlu-Tyr-Pro-NH(2)

248 f this study was to compare the conventional radioimmunoassay (RIA) to an enzyme-linked immunoassay (

249 We utilized a highly sensitive and specific radioimmunoassay (RIA) to immunoreactive, pro-SAAS-deriv

250 osed acute myeloid leukemia (AML), we used a radioimmunoassay (RIA) to quantify VEGF levels in stored

251 The tetramer radioimmunoassay (RIA) was more sensitive for MOG autoan

252 Serum ferritin levels measured by radioimmunoassay (RIA) were greater in 75 patients at ri

253 nzyme linked immunosorbent assay (ELISA) and radioimmunoassay (RIA)) has been unsuccessful.

254 ndent methods: receptor binding assay (RBA), radioimmunoassay (RIA), neuroblastoma (N2A) cytotoxicity

255 spray ionization mass spectrometry (ESI-MS), radioimmunoassay (RIA), receptor binding, and hyperinsul

256 cAMP in the tissue extract was determined by radioimmunoassay (RIA).

257 al nervous system of adult human brain using radioimmunoassay (RIA).

258 dies [confocal immunocytochemistry (ICC) and radioimmunoassay (RIA)].

259 e processing in brain and pituitary, we used radioimmunoassays (RIA) as well as quantitative peptidom

260 , a commercial Farr assay (Ortho Diagnostics radioimmunoassay [RIA]) in which the antigen source is m

261 t PRL (rPRL) and oPRL using species-specific radioimmunoassays (RIAs).

262 erum IGF-binding protein-3 concentration (by radioimmunoassay), serum osmolality, IGF-1 concentration

263 Immunohistochemistry and radioimmunoassay showed hGH protein in the hypothalamus

264 Plasma radioimmunoassays showed elevated gastrin, chromogranin

265 ion localized at postsynaptic junctions, and radioimmunoassays showed more profound reductions in ACh

266 Analysis of peptide levels using a radioimmunoassay shows that these PDYN(R212W) mice displ

267 the experiments and the samples analyzed by radioimmunoassay; Tc was monitored continuously using th

268 monophosphate (cyclic GMP) were measured by radioimmunoassay technique.

269 te with the use of in vivo microdialysis and radioimmunoassay techniques that SP is also released wit

270 ction during blood sampling, and nonspecific radioimmunoassay techniques.

271 ion employing peroxidase anti-peroxidase and radioimmunoassay techniques.

272 It usually entails the use of a radioimmunoassay that is expensive and not always readil

273 As in a competitive radioimmunoassay, there is an inverse relationship betwe

274 We used a sensitive radioimmunoassay to measure serum parathyroid hormone-re

275 GF-cb) domains of fibrillin 1 were used in a radioimmunoassay to screen sera from a large group of SS

276 ed electrophysiology, molecular biology, and radioimmunoassay to show that the electrical activity of

277 been detected in the adaptation of the cAMP-radioimmunoassay to the analysis of adenyl cyclase activ

278 n chromatography were combined with specific radioimmunoassays to analyze the processing patterns of

279 sinase derivatives were subsequently used in radioimmunoassays to investigate the reactivity of sera

280 This is also observed by radioimmunoassay under steady-state conditions.

281 age-matched control animals was measured by radioimmunoassay using benzoyl-gly-gly-gly as substrate.

282 A radioimmunoassay was performed to examine antigen bindin

283 ee cortisone to cortisol measured by using a radioimmunoassay was used as an index for 11betaHSD2.

284 ology, microdialysis, in vitro explants, and radioimmunoassay we assessed the involvement of intracel

285 Using Western blot analysis and solid-phase radioimmunoassay, we measured cellular VEGF levels in B-

286 By radioimmunoassay, we measured pretreatment cellular VEGF

287 Using a newly developed radioimmunoassay, wer measured serum concentrations of l

288 the sensitivity and rank correlation for the radioimmunoassay were 74% and 0.45, respectively.

289 f the capture ELISA and previously described radioimmunoassay were assessed, and the results of those

290 Insulin concentrations measured by radioimmunoassay were transformed by their natural logar

291 ption-polymerase chain reaction (RT-PCR) and radioimmunoassay were utilized to measure NPY mRNA and p

292 Double antibody and polyethylene glycol radioimmunoassays were compared.

293 Radioimmunoassays were used for measuring IGF and IGFBP-

294 Radioimmunoassays were used to confirm the immunoreactiv

295 Radioimmunoassays were used to determine cAMP and prosta

296 Cytoplasmic cAMP levels, measured by radioimmunoassay, were increased by forskolin or isoprot

297 bombesin-like peptide levels, determined by radioimmunoassay, were normalized for creatinine.

298 g complexes were measured in the striatum by radioimmunoassay, Western blot, and gel shift analyses,

299 Measured by radioimmunoassay with a synthetic Leu-AVP standard, seru

300 atients to GAD65 was analyzed by competitive radioimmunoassays with the six rFabs to ascertain diseas